CRISTINA BORSILLI: Open Payments
NPI 1629739131 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,778 in 73 payments from 14 companies in 2025. Trend: 2023 $1,804 · 2024 $1,287 · 2025 $1,778
Food & beverage: $1,778
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $501 |
| Janssen Biotech, Inc. | 9 | $347 |
| Madrigal Pharmaceuticals | 6 | $283 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $189 |
| GENZYME CORPORATION | 4 | $103 |
| Ardelyx, Inc. | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| VIVUS LLC | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $28 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, XIFAXAN, DUPIXENT, IBSRELA, LINZESS, ENTYVIO.
Industry payments across IN — which companies pay providers there.
